LXR-623

Overview

LXR-623 is a brain-penetrant partial LXRα and full LXRβ agonist, with IC 50 s of 24 nM and 179 nM, respectively.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Vitamin D Related/Nuclear Receptor | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cancer | Products > Signaling Pathways > LXR

Product Information

• Catalog No.: HY-10629
• CAS No.: 875787-07-8
• Molecular Formula: C21H12ClF5N2
• Molecular Weight: 422.78
• Purity: 99.95%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (5.91 mM); Clear solution
• Availability: In-stock

Source

Original product source